[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @BiotechSho99376 Biotech Shoutouts Biotech Shoutouts posts on X about $bcrx, $astx, debt, astx the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1775500854247747584/interactions)  - X Week XXXXX +171% - X Month XXXXX +11% - X Months XXXXXX -XX% - X Year XXXXXXX +334% ### Mentions: X [#](/creator/twitter::1775500854247747584/posts_active)  - X Week X +40% - X Month XX -XX% - X Months XX +3.90% - X Year XXX +660% ### Followers: XXX [#](/creator/twitter::1775500854247747584/followers)  - X Week XXX +3.10% - X Month XXX +7.90% - X Months XXX +65% - X Year XXX +193% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1775500854247747584/influencer_rank)  ### Social Influence [#](/creator/twitter::1775500854247747584/influence) --- **Social category influence** [cryptocurrencies](/list/cryptocurrencies) XXXX% [finance](/list/finance) XXXX% **Social topic influence** [$bcrx](/topic/$bcrx) 2.13%, [$astx](/topic/$astx) 2.13%, [debt](/topic/debt) 2.13%, [astx](/topic/astx) 2.13%, [$crsp](/topic/$crsp) 2.13%, [$66b](/topic/$66b) 2.13%, [$mltx](/topic/$mltx) 2.13%, [clever](/topic/clever) 2.13%, [$slrn](/topic/$slrn) 2.13%, [$ifrx](/topic/$ifrx) XXXX% **Top accounts mentioned or mentioned by** [@aaronrosenblum5](/creator/undefined) [@richtrades100](/creator/undefined) [@chillnquant](/creator/undefined) [@nachotrust](/creator/undefined) [@ilzizzo](/creator/undefined) [@vprasadmdmph](/creator/undefined) [@melvinriskmgmt](/creator/undefined) [@bioinvestor24](/creator/undefined) [@bioebro](/creator/undefined) [@msollender](/creator/undefined) [@monacobiotech](/creator/undefined) [@avidresearch](/creator/undefined) [@wagscapitalllc](/creator/undefined) [@biovalues](/creator/undefined) [@jfais20](/creator/undefined) [@drmakaryfda](/creator/undefined) [@amaymd](/creator/undefined) [@biohazard3737](/creator/undefined) [@west0cap](/creator/undefined) [@ly4101174](/creator/undefined) **Top assets mentioned** [Asterix Labs (ASTX)](/topic/$astx) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) ### Top Social Posts [#](/creator/twitter::1775500854247747584/posts) --- Top posts by engagements in the last XX hours "$BCRX $ASTX the termination fee says a lot about FTC intervention risk. Doesn't say much about confidence in their own drug to buy another one with the same moa. This space will look different in several years - more entrants. Lots of debt and no cash now. Odd deal" [X Link](https://x.com/BiotechSho99376/status/1978060896346784066) [@BiotechSho99376](/creator/x/BiotechSho99376) 2025-10-14T11:30Z XXX followers, 2301 engagements "$CRSP anyone have a logical thesis (not "bUt ITs CrISpR") that can justify it here at $6.6B cap" [X Link](https://x.com/BiotechSho99376/status/1975934480134164521) [@BiotechSho99376](/creator/x/BiotechSho99376) 2025-10-08T14:41Z XXX followers, 2808 engagements "My $MLTX short thesis wasn't clever but hinged on 1) HS studies produce idiosyncratic placebo response e.g $SLRN Izokibep 'bump' at wk XX vs wk16 $IFRX prior C5a 'high' placebo rates at P2b. 2) HiSCR endpoint variability. 3) Bim data v. high bar to clear 4) Management pumping" [X Link](https://x.com/BiotechSho99376/status/1972607076653531196) [@BiotechSho99376](/creator/x/BiotechSho99376) 2025-09-29T10:19Z XXX followers, 1002 engagements "$IOBT to run another study - ridiculous outcome @VPrasadMDMPH. You're happy to accept leucovorin but $IOBT shouldn't even bother filing even before you have seen mature OS data Either this is the most X faced FDA ever or $IOBT cooked something up" [X Link](https://x.com/BiotechSho99376/status/1972624690587017383) [@BiotechSho99376](/creator/x/BiotechSho99376) 2025-09-29T11:29Z XXX followers, 3013 engagements "@avidresearch Was it powered for efficacy over Oma" [X Link](https://x.com/BiotechSho99376/status/1980250855157690578) [@BiotechSho99376](/creator/x/BiotechSho99376) 2025-10-20T12:32Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Biotech Shoutouts posts on X about $bcrx, $astx, debt, astx the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence cryptocurrencies XXXX% finance XXXX%
Social topic influence $bcrx 2.13%, $astx 2.13%, debt 2.13%, astx 2.13%, $crsp 2.13%, $66b 2.13%, $mltx 2.13%, clever 2.13%, $slrn 2.13%, $ifrx XXXX%
Top accounts mentioned or mentioned by @aaronrosenblum5 @richtrades100 @chillnquant @nachotrust @ilzizzo @vprasadmdmph @melvinriskmgmt @bioinvestor24 @bioebro @msollender @monacobiotech @avidresearch @wagscapitalllc @biovalues @jfais20 @drmakaryfda @amaymd @biohazard3737 @west0cap @ly4101174
Top assets mentioned Asterix Labs (ASTX) CRISPR Therapeutics AG (CRSP) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)
Top posts by engagements in the last XX hours
"$BCRX $ASTX the termination fee says a lot about FTC intervention risk. Doesn't say much about confidence in their own drug to buy another one with the same moa. This space will look different in several years - more entrants. Lots of debt and no cash now. Odd deal"
X Link @BiotechSho99376 2025-10-14T11:30Z XXX followers, 2301 engagements
"$CRSP anyone have a logical thesis (not "bUt ITs CrISpR") that can justify it here at $6.6B cap"
X Link @BiotechSho99376 2025-10-08T14:41Z XXX followers, 2808 engagements
"My $MLTX short thesis wasn't clever but hinged on 1) HS studies produce idiosyncratic placebo response e.g $SLRN Izokibep 'bump' at wk XX vs wk16 $IFRX prior C5a 'high' placebo rates at P2b. 2) HiSCR endpoint variability. 3) Bim data v. high bar to clear 4) Management pumping"
X Link @BiotechSho99376 2025-09-29T10:19Z XXX followers, 1002 engagements
"$IOBT to run another study - ridiculous outcome @VPrasadMDMPH. You're happy to accept leucovorin but $IOBT shouldn't even bother filing even before you have seen mature OS data Either this is the most X faced FDA ever or $IOBT cooked something up"
X Link @BiotechSho99376 2025-09-29T11:29Z XXX followers, 3013 engagements
"@avidresearch Was it powered for efficacy over Oma"
X Link @BiotechSho99376 2025-10-20T12:32Z XXX followers, XXX engagements
/creator/twitter::BiotechSho99376